
Pfizer says a trial has shown its jab is safe and effective for children that age.
An Kildare based immunology expert says the bar will have to be "very high" for approving Covid vaccines for 5 to 11 year olds.
Pfizer says a trial has shown its jab is safe and effective for children that age.
A significantly lower dosage was given than that administered to adults.
Today with @BioNTech_Group, we are proud to announce positive topline results from the pivotal trial of our #COVID19 vaccine in children 5-11 years of age. https://t.co/a1mSEgxNHQ pic.twitter.com/9xGfYEzFuy
— Pfizer Inc. (@pfizer) September 20, 2021
European regulators and NIAC would need to approve extending the rollout to 5 to 11 year olds.
Paul Moynagh, Professor of Immunology at Maynooth University, says any decision will need to be carefully considered
: